Articular chondrocytes and cartilage matrix homeostasis

Articular chondrocytes and cartilage matrix homeostasis refers to the physiological balance maintained by chondrocytes to preserve the structural integrity of the extracellular matrix (ECM) (PMID: 30635453). This process involves an equilibrium between anabolic activities, such as the synthesis of type II collagen and aggrecan, and catabolic activities mediated by enzymes like matrix metalloproteinases (MMPs) and ADAMTS (PMID: 24041575). In diseases like osteoarthritis, this homeostasis is disrupted, leading to progressive cartilage degradation (NIH: StatPearls - Osteoarthritis). Therapeutic strategies aim to restore this balance by inhibiting catabolic pathways or stimulating anabolic repair mechanisms using agents like Sprifermin or Lorecivivint (PMID: 32810408). While not a single molecular target, this system encompasses various signaling pathways including TGF-beta and Wnt/beta-catenin that are critical for joint health (PMID: 29408411). Consequently, this "target" represents a broad therapeutic goal in regenerative medicine and rheumatology rather than a specific protein or receptor.

Other names

Cartilage homeostasisChondrocyte metabolismExtracellular matrix (ECM) homeostasisArticular cartilage maintenance

Regulation of the balance between anabolic and catabolic activities within the articular cartilage extracellular matrix.